MC
Michael T. Constantino
Director

Michael T. Constantino insider trades: Humacyte (HUMA) stock purchases

Director, Humacyte Last trade May 18, 2026 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$10K
Bought, last 12 months
1 buy
10
Open-market trades
since 2020
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 18, 2026HUMA↑ Buy$10K
Apr 7, 2025HUMA↑ Buy$20K
Dec 4, 2024HUMA↑ Buy$20K
Aug 15, 2024HUMA↑ Buy$19K
May 18, 2023HUMA↑ Buy$20K
May 23, 2022HUMA↑ Buy$10K
May 23, 2022NMTR↑ Buy$8K
Nov 22, 2021HUMA↑ Buy$27K
Aug 24, 2021NMTR↑ Buy$21K
Aug 20, 2020NMTR↑ Buy$26K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other HUMA insiders

Open-market trades in the last 12 months

About Michael T. Constantino's insider trades

Michael T. Constantino is a director at Humacyte (HUMA). Since Aug 20, 2020, Michael has reported 10 open-market purchases worth $180K and no sales on SEC Form 4. In the last 12 months: 1 buy ($10K).

Their filings also include grants and awards (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HUMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.